{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:04:11Z","timestamp":1791529451177,"version":"4.3.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Recent studies have shown the presence of SARS-CoV-2-specific antibodies in the milk of breastfeeding mothers vaccinated with mRNA and convalescent. However, limited information is available in lactating women receiving other vaccine platforms used in developing countries, such as the inactivated SARS-CoV-2 vaccine BBIBP-CorV (Sinopharm) and the non-replicating adenovirus vaccines Sputnik V (Gamaleya Institute) and ChAdOx1-S (Oxford AstraZeneca).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here, we evaluated anti-SARS-CoV-2 IgG and IgA levels in both serum and milk samples using a longitudinal and a cross-sectional cohort of 208 breastfeeding vaccinated women from Argentina with or without previous SARS-CoV-2 infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The analysis showed that IgA levels remain constant in serum and milk of breastfeeding mothers between the first and second doses of vector-based vaccines (Sputnik V and ChAdOx1-S). After the second dose, anti-spike IgA was found positive in 100% of the serum samples and in 66% of breastmilk samples. In addition, no significant differences in milk IgA levels were observed in participants receiving BBIBP-CorV, Sputnik V or ChAdOx1-S. IgG levels in milk increased after the second dose of vector-based vaccines. Paired longitudinal samples taken at 45 and 120 days after the second dose showed a decrease in milk IgG levels over time. Study of IgA levels in serum and milk of vaccinated na\u00efve of infection and vaccinated-convalescent breastfeeding participants showed significantly higher levels in vaccinated-convalescent than in participants without previous infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study is relevant to understand the protection against SARS-CoV-2 by passive immunity in newborns and children who are not yet eligible to receive vaccination.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.909995","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T11:00:38Z","timestamp":1664794838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated na\u00efve and convalescent lactating participants"],"prefix":"10.3389","volume":"13","author":[{"given":"Yesica","family":"Longueira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego S.","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio B. Antivero","family":"Battistelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lautaro","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Oviedo Rouco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Valls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A.","family":"Pando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea V.","family":"Gamarnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"B1","unstructured":"Breastfeeding"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9040715","article-title":"Antiviral properties of human milk","volume":"9","author":"Wedekind","year":"2021","journal-title":"Microorganisms"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00428","article-title":"Changes in human milk immunoglobulin profile during prolonged lactation","volume":"8","author":"Czosnykowska-\u0141ukacka","year":"2020","journal-title":"Front Pediatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.109.2.210","article-title":"Risk factors for severe respiratory syncytial virus infection among Alaska native children","volume":"109","author":"Bulkow","year":"2002","journal-title":"Pediatrics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.083","article-title":"Breastfeeding after maternal immunisation during pregnancy: providing immunological protection to the newborn: a review","volume":"32","author":"Maertens","year":"2014","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","first-page":":1-8","DOI":"10.1371\/journal.pone.0070867","article-title":"IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization","volume":"8","author":"Schlaudecker","year":"2013","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":":1-15","DOI":"10.1016\/j.xcrm.2021.100468","article-title":"Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination","volume":"2","author":"Gon\u00e7alves","year":"2021","journal-title":"Cell Rep Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mbio.03192-20","article-title":"Characterization of SARS-CoV-2 RNA, antibodies, and neutralizing capacity in milk produced by women with COVID-19","volume":"12","author":"Pace","year":"2021","journal-title":"MBio"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/0890334420960433","article-title":"Early identification of IgA anti-SARSCoV-2 in milk of mother with COVID-19 infection","volume":"36","author":"Lebr\u00e3o","year":"2020","journal-title":"J Hum Lact"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.801797\/BIBTEX","article-title":"Milk from women diagnosed with COVID-19 does not contain SARS-CoV-2 RNA but has persistent levels of SARS-CoV-2-Specific IgA antibodies","volume":"12","author":"Pace","year":"2021","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":":1-14","DOI":"10.1371\/journal.pone.0249723","article-title":"The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time","volume":"17","author":"Fox","year":"2022","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-020-00805-w","article-title":"Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM\/IgM, IgG and SIgA\/IgA antibodies in human milk","volume":"41","author":"Demers-Mathieu","year":"2020","journal-title":"J Perinatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":":1-15","DOI":"10.1016\/j.celrep.2021.109959","article-title":"Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection","volume":"37","author":"Pullen","year":"2021","journal-title":"Cell Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.738263","article-title":"Maternal transmission of SARS-CoV-2: Safety of breastfeeding in infants born to infected mothers","volume":"9","author":"Al-kuraishy","year":"2021","journal-title":"Front Pediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.1190","article-title":"Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications","volume":"327","author":"Metz","year":"2022","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.1050","article-title":"Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID multinational cohort study","volume":"175","author":"Villar","year":"2021","journal-title":"JAMA Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.5775","article-title":"Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes","volume":"325","author":"Norman","year":"2021","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/S41591-021-01490-8","article-title":"Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy","volume":"27","author":"Dagan","year":"2021","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":":1-19","DOI":"10.3390\/VACCINES10020246","article-title":"Effectiveness and safety of COVID-19 vaccine among pregnant women in real-world studies: A systematic review and meta-analysis","volume":"10","author":"Ma","year":"2022","journal-title":"Vaccines"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2104983","article-title":"Preliminary findings of mRNA covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMC2113891","article-title":"Receipt of mRNA covid-19 vaccines and risk of spontaneous abortion","volume":"385","author":"Zauche","year":"2021","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMC2114466","article-title":"Covid-19 vaccination during pregnancy and first-trimester miscarriage","volume":"385","author":"Magnus","year":"2021","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.15494","article-title":"Spontaneous abortion following COVID-19 vaccination during pregnancy","volume":"326","author":"Kharbanda","year":"2021","journal-title":"JAMA - J Am Med Assoc"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.5782","article-title":"SARS-CoV-2-Specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women","volume":"325","author":"Perl","year":"2021","journal-title":"JAMA"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.03.031","article-title":"Anti-severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after pfizer-BioNTech\/BNT162b2 vaccination","volume":"225","author":"Kelly","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.1929","article-title":"Evaluation of messenger RNA from COVID-19 BTN162b2 and mRNA-1273 vaccines in human milk","volume":"175","author":"Golan","year":"2021","journal-title":"JAMA Pediatr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101393","article-title":"Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands","volume":"47","author":"Juncker","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":":1-11","DOI":"10.1186\/S13073-022-01043-9","article-title":"Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study","volume":"14","author":"Selma-Royo","year":"2022","journal-title":"Genome Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":":1-9","DOI":"10.1089\/bfm.2022.0019","article-title":"Comparative profiles of SARS-CoV-2 spike-specific human milk antibodies elicited by mRNA- and adenovirus-based COVID-19 vaccines","volume":"17","author":"Yang","year":"2022","journal-title":"Breastfeed Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":":1-10","DOI":"10.3390\/vaccines10040629","article-title":"COVID-19 neutralizing antibodies in breast milk of mothers vaccinated with three different vaccines in Mexico","volume":"10","author":"Cabanillas-Bernal","year":"2022","journal-title":"Vaccines"},{"key":"B31","doi-asserted-by":"publisher","first-page":":1-2","DOI":"10.6061\/clinics\/2021\/e3185","article-title":"CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk","volume":"76","author":"Calil","year":"2021","journal-title":"Clinics (Sao Paulo)"},{"key":"B32","unstructured":"Monitor p\u00fablico de vacunaci\u00f3n | argentina.gob.ar"},{"key":"B33","unstructured":"Ayuda en l\u00ednea SISA - sistema integrado de informaci\u00f3n sanitaria argentino"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009161","article-title":"Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina","volume":"17","author":"Ojeda","year":"2021","journal-title":"PloS Pathog"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.898849","article-title":"Coronavirus disease 2019 vaccine booster effects are seen in human milk antibody response","author":"Bender","year":"2022","journal-title":"Front Nutr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd2223\/suppl_file\/abd2223_sm.pdf","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.4897","article-title":"Association of human milk antibody induction, persistence, and neutralizing capacity with SARS-CoV-2 infection vs mRNA vaccination","volume":"176","author":"Young","year":"2022","journal-title":"JAMA Pediatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":":1-10","DOI":"10.1542\/peds.2021-054260\/184351","article-title":"Human milk SARS-CoV-2 antibodies up to 6 months after vaccination","volume":"149","author":"Perez","year":"2022","journal-title":"Pediatrics"},{"key":"B39","doi-asserted-by":"publisher","first-page":":1-13","DOI":"10.1016\/j.isci.2020.101735","article-title":"Robust and specific secretory IgA against SARS-CoV-2 detected in human milk","volume":"23","author":"Fox","year":"2020","journal-title":"iScience"},{"key":"B40","doi-asserted-by":"publisher","first-page":":1-16","DOI":"10.3390\/vaccines10040536","article-title":"The pilot study of immunogenicity and adverse events of a COVID-19 vaccine regimen: Priming with inactivated whole SARS-CoV-2 vaccine (CoronaVac) and boosting with the adenoviral vector (ChAdOx1 nCoV-19) vaccine","volume":"10","author":"Mahasirimongkol","year":"2022","journal-title":"Vaccines"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060853","article-title":"Comparison of immunogenicity and safety of inactivated, adenovirus-vectored, and heterologous adenovirus-Vectored\/mRNA vaccines in patients with systemic lupus erythematosus and rheumatoid arthritis: A prospective cohort study","volume":"10","author":"Assawasaksakul","year":"2022","journal-title":"Vaccines"},{"key":"B42","doi-asserted-by":"publisher","first-page":":1-13","DOI":"10.1016\/j.xcrm.2022.100706","article-title":"Article immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V","volume":"3","author":"Pascuale","year":"2022","journal-title":"Cell Reports Medicine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJOG.2022.04.010","article-title":"Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose","author":"Nevo","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B44","doi-asserted-by":"publisher","first-page":":1-7","DOI":"10.1038\/S41467-021-26507-1","article-title":"BNT162b2 mRNA vaccine elicited antibody response in blood and milk of breastfeeding women","volume":"12","author":"Rosenberg-Friedman","year":"2021","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1983.tb26889.x","article-title":"The origins of secretory iga in milk: a shift during lactation from a serum origin to local synthesis in the mammary gland*","volume":"409","author":"Halsey","year":"1983","journal-title":"Ann N Y Acad Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041069","article-title":"CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate","volume":"200","author":"Wilson","year":"2004","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.909995\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T11:00:40Z","timestamp":1664794840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.909995\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2022.909995"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.909995","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"article-number":"909995"}}